Scarica l'app Stockscreener
20.87
13.18%
2.43
Dopo l'orario di chiusura:
21.00
0.13
+0.62%
Precedente Chiudi:
$18.44
Aprire:
$20.45
Volume 24 ore:
176.41K
Relative Volume:
2.36
Capitalizzazione di mercato:
$1.00B
Reddito:
$27,600
Utile/perdita netta:
$-36.04M
Rapporto P/E:
-26.19
EPS:
-0.7968
Flusso di cassa netto:
$-1.66M
1 W Prestazione:
+8.70%
1M Prestazione:
+10.48%
6M Prestazione:
+515.63%
1 anno Prestazione:
+401.68%
Intervallo 1D:
$20.00
$20.97
Intervallo di 1 settimana:
$14.78
$20.97
Portata 52W:
$2.76
$30.35
Nanobiotix Adr Stock (NBTX) Company Profile
Confronta NBTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
20.87 | 889.09M | 27,600 | -36.04M | -1.66M | -0.7968 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-28 | Iniziato | Guggenheim | Buy |
| 2023-12-08 | Iniziato | Leerink Partners | Outperform |
| 2021-01-06 | Iniziato | Evercore ISI | Outperform |
Nanobiotix Adr Borsa (NBTX) Ultime notizie
Nanobiotix (NASDAQ:NBTX) Stock Price Up 10.3%Still a Buy? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Declines By 60.7% - MarketBeat
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances - MSN
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M - TipRanks
Nanobiotix (NASDAQ:NBTX) Shares Gap UpStill a Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday - NewsBreak: Local News & Alerts
Carter's, Newmont Corporation And Other Big Stocks Moving Lower In Monday's Pre-Market Session - inkl
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket - Benzinga
Nanobiotix (NASDAQ:NBTX) Shares Down 4.6%Time to Sell? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap DownTime to Sell? - MarketBeat
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer - TipRanks
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Sees Large Growth in Short Interest - MarketBeat
Karooooo Posts Downbeat Earnings, Joins ASP Isotopes And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Orion, Nio, Alibaba Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre Market Movers: NBTX, IMTX, QNRX See Big Swings - RTTNews
Why NioCorp Developments Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - inkl
Nanobiotix (NASDAQ:NBTX) Trading Up 19.2%Here's Why - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Down 12%Should You Sell? - MarketBeat
Weiss Ratings Reiterates "Sell (D-)" Rating for Nanobiotix (NASDAQ:NBTX) - MarketBeat
This Stock Is Up 440% in a Year. Is It an Undiscovered Star or a Flash in the Pan? - Barchart.com
Morning Market Movers: XBIO, UPC, GLTO Spark Big Moves - RTTNews
FY2027 EPS Estimates for Nanobiotix Boosted by HC Wainwright - Defense World
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket - inkl
Morning Market Movers: SPRC, VALN, NBY, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Reaches New 1-Year HighHere's Why - MarketBeat
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC - GlobeNewswire Inc.
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Hits New 52-Week HighHere's Why - MarketBeat
Nanobiotix S.A. Sponsored ADR (NASDAQ:NBTX) Short Interest Up 23.7% in August - MarketBeat
Nanobiotix (NASDAQ:NBTX) Trading 11.8% HigherTime to Buy? - MarketBeat
Biotech Stocks Moving Premarket: QLGN, MBX, HSDT, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Shares Up 5.7%What's Next? - MarketBeat
Nanobiotix announces new results from JNJ-1900 study - TipRanks
Nanobiotix Announces Voting Rights and Share Capital Update - The Globe and Mail
Nanobiotix (NASDAQ:NBTX) Stock Price Down 5.2% – Here’s Why - Defense World
Nanobiotix (NASDAQ:NBTX) Stock Price Up 2.9% – Should You Buy? - Defense World
Guggenheim Reaffirms Their Buy Rating on Nanobiotix (NBTX) - The Globe and Mail
Nanobiotix (NASDAQ:NBTX) Stock Price Down 2.5% – Should You Sell? - Defense World
Nanobiotix announces regulatory harmonization, new patent for JNJ-1900 - TipRanks
Nanobiotix Sa ADR Reports Q1 2025 Progress - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Nanobiotix Adr Azioni (NBTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):